205 related articles for article (PubMed ID: 17696165)
1. Effect of polymer molecular weight on the production of drug nanoparticles.
Sepassi S; Goodwin DJ; Drake AF; Holland S; Leonard G; Martini L; Lawrence MJ
J Pharm Sci; 2007 Oct; 96(10):2655-66. PubMed ID: 17696165
[TBL] [Abstract][Full Text] [Related]
2. Production of nabumetone nanoparticles: Effect of molecular weight, concentration and nature of cellulose ether stabiliser.
Goodwin DJ; Martini LG; Lawrence MJ
Int J Pharm; 2016 Dec; 514(2):428-444. PubMed ID: 27693736
[TBL] [Abstract][Full Text] [Related]
3. Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering.
Goodwin DJ; Sepassi S; King SM; Holland SJ; Martini LG; Lawrence MJ
Mol Pharm; 2013 Nov; 10(11):4146-58. PubMed ID: 24074034
[TBL] [Abstract][Full Text] [Related]
4. Stable carbamazepine colloidal systems using the cosolvent technique.
Douroumis D; Fahr A
Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
[TBL] [Abstract][Full Text] [Related]
5. Anti-tack action of polyvinylpyrrolidone on hydroxypropylmethylcellulose solution.
Chan LW; Wong TW; Chua PC; York P; Heng PW
Chem Pharm Bull (Tokyo); 2003 Feb; 51(2):107-12. PubMed ID: 12576641
[TBL] [Abstract][Full Text] [Related]
6. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the adsorption of hydroxypropylmethyl cellulose 2910 5 mPa s and polyvinylpyrrolidone K90 around Naproxen nanocrystals.
Kayaert P; Van den Mooter G
J Pharm Sci; 2012 Oct; 101(10):3916-23. PubMed ID: 22829442
[TBL] [Abstract][Full Text] [Related]
8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
11. Polymer-drug interactions and wetting of solid dispersions.
Dahlberg C; Millqvist-Fureby A; Schuleit M; Furó I
Eur J Pharm Sci; 2010 Jan; 39(1-3):125-33. PubMed ID: 19932176
[TBL] [Abstract][Full Text] [Related]
12. Initial studies of water granulation of eight grades of hypromellose (HPMC).
Herder J; Adolfsson A; Larsson A
Int J Pharm; 2006 Apr; 313(1-2):57-65. PubMed ID: 16510256
[TBL] [Abstract][Full Text] [Related]
13. A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling.
Ghafourian T; Safari A; Adibkia K; Parviz F; Nokhodchi A
J Pharm Sci; 2007 Dec; 96(12):3334-51. PubMed ID: 17626286
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the film-coating properties of a hydroxyethyl cellulose/hydroxypropyl methylcellulose polymer system.
Li SP; Martellucci SA; Bruce RD; Kinyon AC; Hay MB; Higgins JD
Drug Dev Ind Pharm; 2002 Apr; 28(4):389-401. PubMed ID: 12056532
[TBL] [Abstract][Full Text] [Related]
16. Novel ultra-cryo milling and co-grinding technique in liquid nitrogen to produce dissolution-enhanced nanoparticles for poorly water-soluble drugs.
Sugimoto S; Niwa T; Nakanishi Y; Danjo K
Chem Pharm Bull (Tokyo); 2012; 60(3):325-33. PubMed ID: 22382412
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
18. Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures.
Moribe K; Pongpeerapat A; Tozuka Y; Yamamoto K
Pharmazie; 2006 Feb; 61(2):97-101. PubMed ID: 16526554
[TBL] [Abstract][Full Text] [Related]
19. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
Mitchell SA; Balwinski KM
J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
[TBL] [Abstract][Full Text] [Related]
20. Influence of polyvinylpyrrolidone on aggregation propensity of coated spheroids.
Wong T; Heng P; Yeo T; Chan L
Int J Pharm; 2002 Aug; 242(1-2):357-60. PubMed ID: 12176279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
